Urinary metabolic biomarkers of hepatocellular carcinoma in an Egyptian population: a validation study.
about
Applications of metabolomics in cancer researchMetabolomic analysis of human cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis diseasesHepatocellular carcinoma: Review of disease and tumor biomarkersNuclear magnetic resonance based metabolomics and liver diseases: Recent advances and future clinical applicationsMagnetic Resonance Spectroscopy: Principles and Techniques: Lessons for CliniciansChallenges of liver cancer: Future emerging tools in imaging and urinary biomarkers.NMR-based metabolomics approach to study the chronic toxicity of crude ricin from castor bean kernels on rats.The metabolomic window into hepatobiliary disease.Metabolomics study of stepwise hepatocarcinogenesis from the model rats to patients: potential biomarkers effective for small hepatocellular carcinoma diagnosis.Metabonomic analysis of liver tissue from BALB/c mice with D-galactosamine/lipopolysaccharide-induced acute hepatic failure.Research partnerships between high and low-income countries: are international partnerships always a good thing?The promise of metabolic phenotyping in gastroenterology and hepatology.Chromatographic determination of some biomarkers of liver cirrhosis and hepatocellular carcinoma in Egyptian patients.The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer.Targeted metabolic profiling of hepatocellular carcinoma and hepatitis C using LC-MS/MS.Plasma metabolomic analysis of human hepatocellular carcinoma: Diagnostic and therapeutic studyIncidence and mortality of primary liver cancer in England and Wales: changing patterns and ethnic variations.The aspartate metabolism pathway is differentiable in human hepatocellular carcinoma: transcriptomics and (13) C-isotope based metabolomics.Urinary metabolic profiling by 1H NMR spectroscopy in patients with cirrhosis may discriminate overt but not covert hepatic encephalopathy.A characteristic biosignature for discrimination of gastric cancer from healthy population by high throughput GC-MS analysis.Biofluid metabonomics using (1)H NMR spectroscopy: the road to biomarker discovery in gastroenterology and hepatology.Recent advances in metabolomics in oncology.Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma.Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review.Evaluation of liver cirrhosis and hepatocellular carcinoma using Protein-Protein Interaction Networks.The complex metabolism of trimethylamine in humans: endogenous and exogenous sources.Nuclear magnetic resonance metabolomics and human liver diseases: The principles and evidence associated with protein and carbohydrate metabolism.Urinary nuclear magnetic resonance spectroscopy of a Bangladeshi cohort with hepatitis-B hepatocellular carcinoma: A biomarker corroboration study.The Plasma and Serum Metabotyping of Hepatocellular Carcinoma in a Nigerian and Egyptian Cohort using Proton Nuclear Magnetic Resonance Spectroscopy.Urinary Metabotyping of Hepatocellular Carcinoma in a UK Cohort Using Proton Nuclear Magnetic Resonance Spectroscopy.The utility of biomarkers in hepatocellular carcinoma: review of urine-based 1H-NMR studies - what the clinician needs to know.Proton nuclear magnetic resonance-based metabonomic models for non-invasive diagnosis of liver fibrosis in chronic hepatitis C: Optimizing the classification of intermediate fibrosis.Discovery and validation of urinary metabotypes for the diagnosis of hepatocellular carcinoma in West Africans.Deciphering hepatocellular carcinoma through metabolomics: from biomarker discovery to therapy evaluation.Identification of race-associated metabolite biomarkers for hepatocellular carcinoma in patients with liver cirrhosis and hepatitis C virus infection.Nuclear Magnetic Resonance technique in tumor metabolism
P2860
Q24600728-2B5D2AA7-DF05-4927-8D05-BD670116637EQ26741550-9FEA5D84-FB4A-406F-B8BF-4627009C86D0Q26750796-2CA653B0-2041-4E11-98CA-923FDFBA6DE2Q26772297-D0A4C970-8535-4F63-B7B8-CCCE83CC17ADQ28066771-1360218B-1881-4B06-87DD-116EA0D257BEQ30398077-8DEFC4CC-E135-4821-A11E-26F78ABBA193Q30834994-12523362-6330-4DEB-BB38-DC066F023266Q33893457-E026ECAA-E5F7-4A19-A9FD-76B0DF46F4E7Q34074566-81D09411-A955-4F0E-842F-F92D0719C83CQ34694389-6EE59851-064F-4A16-8291-9179ADF56CDDQ35643371-0DBC3949-33DF-4ED4-8A33-C46AA1D4468FQ35701279-D5C7B702-CD0E-4679-A0CB-CBBAB1F0FCE7Q36197829-BD99CB45-3DF3-4108-80FD-35F0CACA296BQ36683019-E67B8797-80FB-450C-B31E-D017345F6E8EQ37304708-6713D4C6-B503-4B4A-87F2-1FE4ABDC9A41Q37565131-6B5B6E27-0951-4EA3-A92A-EEF75D5B65AFQ37587269-48690F2B-0861-405E-9018-04F2541E7DFFQ37656478-43088B3A-3C8F-44B2-ABC8-F137687B6BA9Q37694261-52939229-F338-43EF-BBEE-9DEA9E563C81Q37699460-1F0E4786-10B8-44DF-8B07-D884A94DD3D4Q37989165-F8AB1AB9-00EA-404E-878A-B484116DE5ABQ37990967-DA423F3D-3BA8-4F44-82A5-C79A924D438BQ38059646-77AC7553-3BEA-4BB1-BBA2-31452D510E27Q38397273-9149856E-FBEA-4D07-B439-A87D60634ACEQ38436698-B6454AA2-245F-41B4-99D7-62A52E7DAAFBQ38820418-08077347-D632-4943-8133-AF08E2C062C0Q38834940-E8F4EC1C-A89B-4D37-B10E-667073B230F5Q39815320-1B37276D-27D5-4026-846F-AEBA9323E6DAQ40140466-DA790E06-07D0-4899-8DEE-97F2C899D14DQ40539605-76C2876E-0433-4453-8F2E-E76BFD2C8611Q47162797-B93F46F1-2A15-43C6-8D11-D921EB4F7B5AQ48513520-58D46F55-2830-42EA-B2BC-D74C369ABD1FQ50573694-C74FA138-E71B-4330-B2C5-AAF09473C19BQ52564715-5AC3A1BE-3AD6-4171-BF85-ABD31D830679Q54256088-A88EAA66-F1BD-4F70-9B0C-4DEEE22D4814Q57095244-61CAEC91-3D8A-48D3-B25A-E6EA826B9E6A
P2860
Urinary metabolic biomarkers of hepatocellular carcinoma in an Egyptian population: a validation study.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Urinary metabolic biomarkers o ...... opulation: a validation study.
@en
Urinary metabolic biomarkers o ...... opulation: a validation study.
@nl
type
label
Urinary metabolic biomarkers o ...... opulation: a validation study.
@en
Urinary metabolic biomarkers o ...... opulation: a validation study.
@nl
prefLabel
Urinary metabolic biomarkers o ...... opulation: a validation study.
@en
Urinary metabolic biomarkers o ...... opulation: a validation study.
@nl
P2093
P50
P356
P1476
Urinary metabolic biomarkers o ...... population: a validation study
@en
P2093
Andrew V Thillainayagam
Horace R T Williams
Howard C Thomas
Madhvi Patel
Mary M E Crossey
Mohamed I F Shariff
Shahid A Khan
Simon D Taylor-Robinson
P304
P356
10.1021/PR101096F
P577
2011-03-09T00:00:00Z